U.S., Jan. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07315022) titled 'Enhanced Recovery After Surgery-Based Multimodal Preemptive Analgesia for Perioperative Management in Transarterial Chemoembolization of Intermediate-to-Advanced Hepatocellular Carcinoma' on Dec. 05, 2025.
Brief Summary: To evaluate the effectiveness of the combination of hydrochloride hydromorphone and flurbiprofen ester for post-TACE intravenous patient-controlled intravenous analgesia (PCIA).
Study Start Date: Aug. 01, 2024
Study Type: INTERVENTIONAL
Condition:
Enhanced Recovery After Surgery
Multimodal Analgesia
Real-world Study
Transarterial Chemoembolization
Intervention:
DRUG: hydrochloride hydromorphone + flurbiprofen a...